Vision Pharmacoat Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 20-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 20-06-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 23.12 Cr
as on 20-06-2024
- Revenue -15.35%
(FY 2022)
- Profit 18.82%
(FY 2022)
- Ebitda 14.80%
(FY 2022)
- Net Worth 26.31%
(FY 2022)
- Total Assets 24.52%
(FY 2022)
About Vision Pharmacoat
The Corporate was formerly known as Ravalgaon Foods Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹23.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pawankumar Agrawal and Krishnadevi Agrawal serve as directors at the Company.
- CIN/LLPIN
U74999TG1999PTC113378
- Company No.
113378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vision Pharmacoat?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawankumar Agrawal  | Director | 07-Apr-1999 | Current |
| Krishnadevi Agrawal | Director | 07-Apr-1999 | Current |
Financial Performance and Corporate Structure Insights of Vision Pharmacoat.
Vision Pharmacoat Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.35% decrease. The company also saw a substantial improvement in profitability, with a 18.82% increase in profit. The company's net worth Soared by an impressive increase of 26.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vision Pharmacoat?
In 2022, Vision Pharmacoat had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivshakti Drugs Private LimitedActive 24 years 6 monthsPawankumar Agrawal and Krishnadevi Agrawal are mutual person
Vaikuntha Intermediates Private LimitedActive 4 years 11 monthsPawankumar Agrawal and Krishnadevi Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Nov 2019 | ₹13.99 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 26 Oct 2017 | ₹4.43 Cr | Satisfied |
A.P.Mahesh Urban Co-Op. Bank Ltd. Kukatpally Branch Creation Date: 14 Sep 2015 | ₹2.80 Cr | Satisfied |
How Many Employees Work at Vision Pharmacoat?
Unlock and access historical data on people associated with Vision Pharmacoat, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vision Pharmacoat, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vision Pharmacoat's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
